$NLSP Target PTs 2.39-3 and higherNLS Pharmaceutics Announces Patent Issuance in the United States for its Mazindol Extended-Release Formulation
Key patent now granted in major markets including the U.S., Europe, Canada & South Korea
Patent claims cover use of the Company's lead product candidate, Quilience® (mazindol ER) in both
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.19 USD
−12.17 M USD
0.00 USD
1.78 M
About NLS Pharmaceutics Ltd.
Sector
CEO
Alexander C. Zwyer
Headquarters
Zurich
Website
Founded
2015
ISIN
CH1384053976
FIGI
BBG00S2L23F4
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.
NLS Obtains License to Full Regulatory Data Package and know-howNLS Pharmaceutics Obtains License to Full Regulatory Data Package and Proprietary Know-How for Sanorex® (Mazindol)
Agreement provides exclusive rights to all available data included in the original new drug application ("NDA") for mazindol in the U.S.
$NLSP announces that it has entered into a Lic
NLS Pharmaceutics + 200%NLS Pharmaceutics (NASDAQ:NLSP) announces that it has entered into a License Agreement with Novartis Pharma AG, for all of the available data in the original NDA for Sanorex (mazindol) submitted to the U.S. FDA in February 1972
Share your opinion in the comments and support the idea with likes.
Tha
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NLSP is 3.94 USD — it has decreased by −5.06% in the past 24 hours. Watch NLS Pharmaceutics Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NLS Pharmaceutics Ltd. stocks are traded under the ticker NLSP.
NLSP stock has risen by 3.41% compared to the previous week, the month change is a −24.52% fall, over the last year NLS Pharmaceutics Ltd. has showed a −84.85% decrease.
NLSP reached its all-time high on Mar 12, 2021 with the price of 294.00 USD, and its all-time low was 3.51 USD and was reached on Oct 30, 2024. View more price dynamics on NLSP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NLSP stock is 7.79% volatile and has beta coefficient of 0.51. Track NLS Pharmaceutics Ltd. stock price on the chart and check out the list of the most volatile stocks — is NLS Pharmaceutics Ltd. there?
Today NLS Pharmaceutics Ltd. has the market capitalization of 9.74 M, it has decreased by −13.16% over the last week.
Yes, you can track NLS Pharmaceutics Ltd. financials in yearly and quarterly reports right on TradingView.
NLS Pharmaceutics Ltd. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
NLSP net income for the last half-year is −2.04 M USD, while the previous report showed −4.56 M USD of net income which accounts for 55.35% change. Track more NLS Pharmaceutics Ltd. financial stats to get the full picture.
No, NLSP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 11, 2024, the company has 4.00 employees. See our rating of the largest employees — is NLS Pharmaceutics Ltd. on this list?
Like other stocks, NLSP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NLS Pharmaceutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NLS Pharmaceutics Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NLS Pharmaceutics Ltd. stock shows the sell signal. See more of NLS Pharmaceutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.